Valuation Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
12:33:33 2026-08-31 pm EDT
|
5-day change | 1st Jan Change | ||
| 56.84 USD | -1.66% |
|
-2.20% | +29.22% |
| Aug. 21 | Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says | MT |
| Aug. 21 | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
Company Valuation: Scholar Rock Holding Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 872.1 | 467.6 | 1,356 | 4,046 | 4,493 | 7,039 | - | - |
| Change | - | -46.39% | 190.08% | 198.32% | 11.06% | 56.66% | - | - |
| Enterprise Value (EV) 1 | 709.3 | 414 | 1,304 | 3,918 | 4,270 | 6,722 | 6,634 | 6,669 |
| Change | - | -41.63% | 215.07% | 200.38% | 8.97% | 57.44% | -1.31% | 0.53% |
| P/E | -6.92x | -4x | -9.45x | -17.5x | -13.4x | -17.8x | -22.5x | -37.5x |
| PBR | 5.3x | 2.07x | 6.96x | 11x | 20.6x | 26.5x | 23.7x | 26.3x |
| PEG | - | 0.1x | 0.8x | -0.7x | -0.4x | 13.93x | 1.1x | 0.9x |
| Capitalization / Revenue | 46.3x | 14.1x | - | - | - | 1,238x | 48.2x | 20.2x |
| EV / Revenue | 37.7x | 12.5x | - | - | - | 1,183x | 45.4x | 19.1x |
| EV / EBITDA | -5.57x | - | - | - | -11.1x | -15.7x | -22.5x | -69.1x |
| EV / EBIT | -5.46x | -3.08x | -7.62x | -15.5x | -11.1x | -15.4x | -19x | -34.7x |
| EV / FCF | -5.37x | -3.1x | -8.98x | -19.5x | -14.2x | -20.1x | -30.5x | -84.4x |
| FCF Yield | -18.6% | -32.3% | -11.1% | -5.13% | -7.04% | -4.98% | -3.28% | -1.18% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.59 | -2.26 | -1.99 | -2.47 | -3.29 | -3.248 | -2.572 | -1.542 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18.82 | 33.19 | - | - | - | 5.684 | 146.1 | 348.8 |
| EBITDA 1 | -127.3 | - | - | - | -383 | -429 | -295.2 | -96.48 |
| EBIT 1 | -129.9 | -134.4 | -171.3 | -252.1 | -384.6 | -437.7 | -348.9 | -192.3 |
| Net income 1 | -131.8 | -134.5 | -165.8 | -246.3 | -377.9 | -425.3 | -363.8 | -213.1 |
| Net Debt 1 | -162.8 | -53.53 | -51.84 | -127.7 | -223.8 | -317.2 | -404.9 | -369.9 |
| Reference price 2 | 24.84 | 9.05 | 18.80 | 43.22 | 44.05 | 57.80 | 57.80 | 57.80 |
| Nbr of stocks (in thousands) | 35,108 | 51,663 | 72,143 | 93,615 | 102,007 | 121,785 | - | - |
| Announcement Date | 3/7/22 | 3/7/23 | 3/19/24 | 2/27/25 | 3/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.8x | 1182.61x | -15.67x | -.--% | 7.04B | |
| 20.59x | 7.25x | 14.66x | 1.42% | 69.54B | |
| 36.89x | 9.62x | 29.41x | 0.04% | 64.97B | |
| 30.69x | 6.58x | 17.2x | -.--% | 26.51B | |
| -72.56x | 13.98x | -67.43x | -.--% | 25.89B | |
| -15.61x | 5.94x | -7.46x | -.--% | 25.64B | |
| 58.27x | 21.67x | 43.95x | 0.26% | 20.22B | |
| 27.27x | 5.11x | 16.98x | -.--% | 19.98B | |
| 1415.29x | 39.34x | 858.54x | -.--% | 15.69B | |
| 16.84x | 5x | 11.66x | -.--% | 13.49B | |
| Average | 149.99x | 129.71x | 90.18x | 0.17% | 28.9B | |
| Weighted average by Cap. | 91.32x | 39.34x | 56.03x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SRRK Stock
- Valuation Scholar Rock Holding Corporation
Select your edition
All financial news and data tailored to specific country editions
